CD276 and neuroblastoma: In addition, blocking B7-H3 expression with 5B14, an anti–B7-H3 IgM mAb, led to enhanced NK cell–mediated killing of neuroblastoma cells freshly isolated from the bone marrow of newly diagnosed stage M patients (1).